Views & Analysis COVID-19 – Delivering a pandemic of change to digital medica... As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving to digital solutions.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.